Clinical Trial Update: Effect of Vitamin D3 Supplementation on Insulin Resistance and Cardiovascular Risk Factors in Obese Adolescents [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of Vitamin D3 (cholecalciferol) supplementation on insulin resistance and cardiovascular risk factors in obese adolescents, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Mayo Clinic | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2014-03-06